MiR-130 exerts tumor suppressive function on the tumorigenesis of human non-small cell lung cancer by targeting PTEN

Por Ye, Ling, Wang, Yiming, Nie, Lin, Qian, Shen, Xu, Meng
Publicado no Am J Transl Res (2017)

Raising the bar for enthusiasm when looking at results of randomized phase II trials—the case of sunitinib in small-cell lung cancer

Por Di Maio, Massimo, Bironzo, Paolo, Scagliotti, Giorgio Vittorio
Publicado no Transl Lung Cancer Res (2016)

Statistical control process to compare and rank treatment plans in radiation oncology: impact of heterogeneity correction on treatment planning in lung cancer

Por Chaikh, Abdulhamid, Balosso, Jacques
Publicado no Transl Lung Cancer Res (2016)

Silencing of advanced glycosylation and glycosylation and product-specific receptor (RAGE) inhibits the metastasis and growth of non-small cell lung cancer

Por Yu, Yan Xia, Pan, Wen Chong, Cheng, Yu Feng
Publicado no Am J Transl Res (2017)

Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatment

Por Nel, Ivonne, Jehn, Ulrich, Gauler, Thomas, Hoffmann, Andreas-Claudius
Publicado no Transl Lung Cancer Res (2014)

Tumor profiling of co-regulated receptor tyrosine kinase and chemoresistant genes reveal different targeting options for lung and gastroesophageal cancers

Por Wu, Jianzhong, Li, Shuchun, Ma, Rong, Sharma, Ashok, Bai, Shan, Dun, Boying, Cao, Haixia, Jing, Changwen, She, Jinxiong, Feng, Jifeng
Publicado no Am J Transl Res (2016)

Methylation of kruppel-like factor 2 (KLF2) associates with its expression and non-small cell lung cancer progression

Por Jiang, Wenbin, Xu, Xueqing, Deng, Shaoli, Luo, Jie, Xu, Huan, Wang, Chao, Sun, Tingting, Lei, Guoqin, Zhang, Fengling, Yang, Cheng, Zhou, Lin, Wang, Feng, Chen, Ming
Publicado no Am J Transl Res (2017)

P22. The serum levels, phenotypes and expression of alpha-1-antitrypsin in non-small cell lung cancer—pilot study

Por Szpechcinski, Adam, Langfort, Renata, Poplawska-Wisniewska, Beata, Giedronowicz, Dorota, Kupis, Wlodzimierz, Rudzinski, Piotr, Zaleska, Jolanta, Orlowski, Tadeusz, Roszkowski-Sliz, Kazimierz, Chorostowska-Wynimko, Joanna
Publicado no Transl Lung Cancer Res (2014)

Prognostic value of circulating endothelial cells in non-small cell lung cancer patients: a systematic review and meta-analysis

Por Liu, Yafang, Yuan, Dongmei, Ye, Wei, Lv, Tangfeng, Song, Yong
Publicado no Transl Lung Cancer Res (2015)

P19. Overall survival in advanced lung cancer patients proposed to receive initial chemotherapy according to actual chemotherapy delivery

Por Knez, Lea, Sadikov, Aleksander, Jakelj, Andraž, Mohorcic, Katja, Hitij, Nina Turnšek, Cufer, Tanja
Publicado no Transl Lung Cancer Res (2014)

Spread through air spaces (STAS): a comprehensive update

Por Warth, Arne
Publicado no Transl Lung Cancer Res (2017)

Update on large cell neuroendocrine carcinoma

Por Hiroshima, Kenzo, Mino-Kenudson, Mari
Publicado no Transl Lung Cancer Res (2017)

Classification of pulmonary neuroendocrine tumors: new insights

Por Pelosi, Giuseppe, Sonzogni, Angelica, Harari, Sergio, Albini, Adriana, Bresaola, Enrica, Marchiò, Caterina, Massa, Federica, Righi, Luisella, Gatti, Gaia, Papanikolaou, Nikolaos, Vijayvergia, Namrata, Calabrese, Fiorella, Papotti, Mauro
Publicado no Transl Lung Cancer Res (2017)

Erratum to combination MET- and EGFR-directed therapy in MET-overexpressing non-small cell lung cancers: time to move on to better biomarkers?

Publicado no Transl Lung Cancer Res (2017)

Nivolumab as first line monotherapy for advanced non-small cell lung cancer: could we replace first line chemotherapy with immunotherapy?

Por West, Howard
Publicado no Transl Lung Cancer Res (2014)

Treatment of limited-stage small cell lung cancer in the elderly, chemotherapy vs. sequential...

Por Gridelli, Cesare, Casaluce, Francesca, Sgambato, Assunta, Monaco, Fabio, Guida, Cesare
Publicado no Transl Lung Cancer Res (2016)

Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future?

Por Bertolaccini, Luca, Terzi, Alberto, Ricchetti, Francesco, Alongi, Filippo
Publicado no Ann Transl Med (2015)

Clinical activity of the mutant-selective EGFR inhibitor AZD9291 in patients with EGFR inhibitor—resistant non-small cell lung cancer

Por Jiang, Tao, Zhou, Caicun
Publicado no Transl Lung Cancer Res (2014)

Is overall survival still the primary endpoint in maintenance non-small cell lung cancer studies? An analysis of phase III randomised trials

Por Petrelli, Fausto, Barni, Sandro
Publicado no Transl Lung Cancer Res (2013)

Inhibiting CREPT reduces the proliferation and migration of non-small cell lung cancer cells by down-regulating cell cycle related protein

Por Liu, Tao, Li, Wei-Miao, Wang, Wu-Ping, Sun, Ying, Ni, Yun-Feng, Xing, Hao, Xia, Jing-Hua, Wang, Xue-Jiao, Zhang, Zhi-Pei, Li, Xiao-Fei
Publicado no Am J Transl Res (2016)